Epigenetic mechanisms in cardiac development and disease

Acta Biochimica et Biophysica Sinica

Volumn 44, Issue 1, 2012, Pages 92-102

  Vallaster, Marcus ^a   Vallaster, Caroline Dacwag ^a,b   Wu, Sean M ^a,b,c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c HARVARD STEM CELL INSTITUTE   (United States)

Author keywords

congenital heart disease; DNA methylation; epigenetics; histone modifications

Indexed keywords

HELICASE; HOMEODOMAIN PROTEIN; NKX2 5 PROTEIN, HUMAN; NKX2-5 PROTEIN, HUMAN; NONHISTONE PROTEIN; NUCLEAR PROTEIN; SMARCA4 PROTEIN, HUMAN; SWI SNF B CHROMATIN REMODELING COMPLEX; SWI-SNF-B CHROMATIN-REMODELING COMPLEX; TRANSCRIPTION FACTOR;

ANIMAL; ARM MALFORMATION; CELL DIFFERENTIATION; CHROMATIN; CONGENITAL HEART MALFORMATION; DIGEORGE SYNDROME; EMBRYONIC STEM CELL; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETICS; HEART; HEART SEPTUM DEFECT; HUMAN; LEG MALFORMATION; METABOLISM; MULTIPLE MALFORMATION SYNDROME; NUCLEOSOME; PHYSIOLOGY; PRENATAL DEVELOPMENT; REVIEW; SYNDROME CHARGE; WOLF HIRSCHHORN SYNDROME;

ABNORMALITIES, MULTIPLE; ANIMALS; CELL DIFFERENTIATION; CHARGE SYNDROME; CHROMATIN; CHROMOSOMAL PROTEINS, NON-HISTONE; DIGEORGE SYNDROME; DNA HELICASES; EMBRYONIC STEM CELLS; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HEART; HEART DEFECTS, CONGENITAL; HEART SEPTAL DEFECTS, ATRIAL; HOMEODOMAIN PROTEINS; HUMANS; LOWER EXTREMITY DEFORMITIES, CONGENITAL; NUCLEAR PROTEINS; NUCLEOSOMES; TRANSCRIPTION FACTORS; UPPER EXTREMITY DEFORMITIES, CONGENITAL; WOLF-HIRSCHHORN SYNDROME;

MAMMALIA;

EID: 84555206235     PISSN: 16729145     EISSN: 17457270     Source Type: Journal    
DOI: 10.1093/abbs/gmr090     Document Type: Review

References (103)

1. Lamarck JB. Zoological philosophy. Reprint from 1914. Ithaca: Cornell University Library, 2009, 106-127.
2. Goldberg AD, Allis CD and Bernstein E. Epigenetics: a landscape takes shape. Cell 2007, 128: 635-638.
3. Wu SM, Fujiwara Y, Cibulsky SM, Clapham DE, Lien CL, Schultheiss TM and Orkin SH. Developmental origin of a bipotential myocardial and smooth muscle cell precursor in the mammalian heart. Cell 2006, 127: 1137-1150.
4. Brand T. Heart development: molecular insights into cardiac specification and early morphogenesis. Dev Biol 2003, 258: 1-19.
5. Buckingham M, Meilhac S and Zaffran S. Building the mammalian heart from two sources of myocardial cells. Nat Rev Genet 2005, 6: 826-835.
6. Ragkousi K, Beh J, Sweeney S, Starobinska E and Davidson B. A single GATA factor plays discrete, lineage specific roles in ascidian heart development. Dev Biol 2011, 352: 154-163.
7. Reamon-Buettner SM and Borlak J. NKX2-5: an update on this hypermutable homeodomain protein and its role in human congenital heart disease (CHD). Hum Mutat 2010, 31: 1185-1194.
8. Puskaric S, Schmitteckert S, Mori AD, Glaser A, Schneider KU, Bruneau BG and Blaschke RJ, et al. Shox2 mediates Tbx5 activity by regulating Bmp4 in the pacemaker region of the developing heart. Hum Mol Genet 2010, 19: 4625-4633.
9. Hang CT, Yang J, Han P, Cheng HL, Shang C, Ashley E and Zhou B, et al. Chromatin regulation by Brg1 underlies heart muscle development and disease. Nature 2010, 466: 62-67.
10. He A, Kong SW, Ma Q and Pu WT. Co-occupancy by multiple cardiac transcription factors identifies transcriptional enhancers active in heart. Proc Natl Acad Sci USA 2011, 108: 5632-5637.
11. Han P, Hang CT, Yang J and Chang CP. Chromatin remodeling in cardiovascular development and physiology. Circ Res 2011, 108: 378-396
12. Backs J and Olson EN. Control of cardiac growth by histone acetylation/ deacetylation. Circ Res 2006, 98: 15-24
13. Mano H. Epigenetic abnormalities in cardiac hypertrophy and heart failure. Environ Health Prev Med 2008, 13: 25-29.
14. Kou CY, Lau SL, Au KW, Leung PY, Chim SS, Fung KP and Waye MM, et al. Epigenetic regulation of neonatal cardiomyocytes differentiation. Biochem Biophys Res Commun 2010, 400: 278-283.
15. Tsuchihashi T, Maeda J, Shin C, Ivey KN, Black B, Olson EN and Yamagishi H, et al. Hand2 function in second heart field progenitors is essential for Cardiogenesis. Dev Biol 2010, 351: 62-69.
16. Butler TL, Esposito G, Blue GM, Cole AD, Costa MW, Waddell LB and Walizada G, et al. GATA4 mutations in 357 unrelated patients with congenital heart malformation. Genet Test Mol Biomarkers 2010, 14: 797-802.
17. Luger K, Mader AW, Richmond RK, Sargent DF and Richmond TJ. Crystal structure of the nucleosome core particle at 2.8 A resolution. Nature 1997, 389: 251-260.
18. Luger K and Richmond TJ. DNA binding within the nucleosome core. Curr Opin Struct Biol 1998, 8: 33-40.
19. Luger K and Richmond TJ. The histone tails of the nucleosome. Curr Opin Genet Dev 1998, 8: 140-146.
20. Imbalzano AN. Energy-dependent chromatin remodelers: complex complexes and their components. Crit Rev Eukaryot Gene Expr 1998, 8: 225-255.
21. Peterson CL. ATP-dependent chromatin remodeling: going mobile. FEBS Lett 2000, 476: 68-72.
22. Aalfs JD and Kingston RE. What does 'chromatin remodeling' mean? Trends Biochem Sci 2000, 25: 548-555.
23. Hargreaves DC and Crabtree GR. ATP-dependent chromatin remodeling: genetics, genomics and mechanisms. Cell Res 2011, 21: 396-420.
24. Persson J and Ekwall K. Chd1 remodelers maintain open chromatin and regulate the epigenetics of differentiation. Exp Cell Res 2010, 316: 1316-1323.
25. Becker PB. Nucleosome sliding: facts and fiction. EMBO J 2002, 21: 4749-4753.
26. Becker PB and Horz W. ATP-dependent nucleosome remodeling. Annu Rev Biochem 2002, 71: 247-273.
27. Workman JL. Nucleosome displacement in transcription. Genes Dev 2006, 20: 2009-2017.
28. Albini S and Puri PL. SWI/SNF complexes, chromatin remodeling and skeletal myogenesis: it's time to exchange! Exp Cell Res 2010, 316: 3073-3080.
29. Lessard JA and Crabtree GR. Chromatin regulatory mechanisms in pluripotency. Annu Rev Cell Dev Biol 2010, 26: 503-532.
30. Saladi SV and de la Serna IL. ATP dependent chromatin remodeling enzymes in embryonic stem cells. Stem Cell Rev 2010, 6: 62-73.
31. Ordovas JM and Smith CE. Epigenetics and cardiovascular disease. Nat Rev Cardiol 2010, 7: 510-519.
32. Eilertsen KJ, Floyd Z and Gimble JM. The epigenetics of adult (somatic) stem cells. Crit Rev Eukaryot Gene Expr 2008, 18: 189-206.
33. Atkinson S and Armstrong L. Epigenetics in embryonic stem cells: regulation of pluripotency and differentiation. Cell Tissue Res 2008, 331: 23-29.
34. Bernstein BE, Mikkelsen TS, Xie X, Kamal M, Huebert DJ, Cuff J and Fry B, et al. A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell 2006, 125: 315-326.
35. Mikkelsen TS, Ku M, Jaffe DB, Issac B, Lieberman E, Giannoukos Gand Alvarez P, et al. Genome-wide maps of chromatin state in pluripotent and lineage-committed cells. Nature 2007, 448: 553-560.
36. Marmorstein R and Roth SY. Histone acetyltransferases: function, structure, and catalysis. Curr Opin Genet Dev 2001, 11: 155-161.
37. Chan HM and La Thangue NB. p300/CBP proteins: HATs for transcriptional bridges and scaffolds. J Cell Sci 2001, 114: 2363-2373.
38. McKinsey TA and Olson EN. Cardiac histone acetylation-therapeutic opportunities abound. Trends Genet 2004, 20: 206-213.
39. Haberland M, Montgomery RL and Olson EN. The many roles of histone deacetylases in development and physiology: implications for disease and therapy. Nat Rev Genet 2009, 10: 32-42.
40. Meissner A. Epigenetic modifications in pluripotent and differentiated cells. Nat Biotechnol 2010, 28: 1079-1088.
41. Melcer S and Meshorer E. Chromatin plasticity in pluripotent cells. Essays Biochem 2010, 48: 245-262.
42. Mattout A and Meshorer E. Chromatin plasticity and genome organization in pluripotent embryonic stem cells. Curr Opin Cell Biol 2010, 22: 334-341.
43. Bondue A, Tannler S, Chiapparo G, Chabab S, Ramialison M, Paulissen C and Beck B, et al. Defining the earliest step of cardiovascular progenitor specification during embryonic stem cell differentiation. J Cell Biol 2011, 192: 751-765.
44. Meilhac SM, Esner M, Kelly RG, Nicolas JF and Buckingham ME. The clonal origin of myocardial cells in different regions of the embryonic mouse heart. Dev Cell 2004, 6: 685-698.
45. Vincent SD and Buckingham ME. How to make a heart: the origin and regulation of cardiac progenitor cells. Curr Top Dev Biol 2010, 90: 1-41.
46. Ma Q, Zhou B and Pu WT. Reassessment of Isl1 and Nkx2-5 cardiac fate maps using a Gata4-based reporter of Cre activity. Dev Biol 2008, 323: 98-104.
47. Dettman RW, Denetclaw W, Jr, Ordahl CP and Bristow J. Common epicardial origin of coronary vascular smooth muscle, perivascular fibroblasts, and intermyocardial fibroblasts in the avian heart. Dev Biol 1998, 193: 169-181.
48. Gittenberger-de Groot AC, Vrancken Peeters MP, Mentink MM, Gourdie RG and Poelmann RE. Epicardium-derived cells contribute a novel population to the myocardial wall and the atrioventricular cushions. Circ Res 1998, 82: 1043-1052.
49. Manner J. Does the subepicardial mesenchyme contribute myocardioblasts to the myocardium of the chick embryo heart? A quail-chick chimera study tracing the fate of the epicardial primordium. Anat Rec 1999, 255: 212-226.
50. Mikawa T and Gourdie RG. Pericardial mesoderm generates a population of coronary smooth muscle cells migrating into the heart along with ingrowth of the epicardial organ. Dev Biol 1996, 174: 221-232.
51. Wessels A and Perez-Pomares JM. The epicardium and epicardially derived cells (EPDCs) as cardiac stem cells. Anat Rec A Discov Mol Cell Evol Biol 2004, 276: 43-57.
52. Zhou B, Ma Q, Rajagopal S, Wu SM, Domian I, Rivera-Feliciano J and Jiang D, et al. Epicardial progenitors contribute to the cardiomyocyte lineage in the developing heart. Nature 2008, 454: 109-113.
53. Ho L and Crabtree GR. Chromatin remodelling during development. Nature 2010, 463: 474-484.
54. Morrison AJ and Shen X. Chromatin remodelling beyond transcription: the INO80 and SWR1 complexes. Nat Rev Mol Cell Biol 2009, 10: 373-384.
55. Ho L, Ronan JL, Wu J, Staahl BT, Chen L, Kuo A and Lessard J, et al. An embryonic stem cell chromatin remodeling complex, esBAF, is essential for embryonic stem cell self-renewal and pluripotency. Proc Natl Acad Sci USA 2009, 106: 5181-5186.
56. Ho L, Jothi R, Ronan JL, Cui K, Zhao K and Crabtree GR. An embryonic stem cell chromatin remodeling complex, esBAF, is an essential component of the core pluripotency transcriptional network. Proc Natl Acad Sci USA 2009, 106: 5187-5191.
57. Yan Z, Wang Z, Sharova L, Sharov AA, Ling C, Piao Y and Aiba K, et al. BAF250B-associated SWI/SNF chromatin-remodeling complex is required to maintain undifferentiated mouse embryonic stem cells. Stem Cells 2008, 26: 1155-1165.
58. Kidder BL, Palmer S and Knott JG. SWI/SNF-Brg1 regulates selfrenewal and occupies core pluripotency-related genes in embryonic stem cells. Stem Cells 2009, 27: 317-328.
59. Lickert H, Takeuchi JK, Von Both I, Walls JR, McAuliffe F, Adamson SL and Henkelman RM, et al. Baf60c is essential for function of BAF chromatin remodelling complexes in heart development. Nature 2004, 432: 107-112.
60. Takeuchi JK and Bruneau BG. Directed transdifferentiation of mouse mesoderm to heart tissue by defined factors. Nature 2009, 459: 708-711.
61. Huang X, Gao X, Diaz-Trelles R, Ruiz-Lozano P and Wang Z. Coronary development is regulated by ATP-dependent SWI/SNF chromatin remodeling component BAF180. Dev Biol 2008, 319: 258-266.
62. Wang Z, Zhai W, Richardson JA, Olson EN, Meneses JJ, Firpo MT and Kang C, et al. Polybromo protein BAF180 functions in mammalian cardiac chamber maturation. Genes Dev 2004, 18: 3106-3116.
63. Ryme J, Asp P, Bohm S, Cavellan E and Farrants AK. Variations in the composition of mammalian SWI/SNF chromatin remodelling complexes. J Cell Biochem 2009, 108: 565-576.
64. Zeng L, Zhang Q, Li S, Plotnikov AN, Walsh MJ and Zhou MM. Mechanism and regulation of acetylated histone binding by the tandem PHD finger of DPF3b. Nature 2010, 466: 258-262.
65. Kaynak B, von Heydebreck A, Mebus S, Seelow D, Hennig S, Vogel J and Sperling HP, et al. Genome-wide array analysis of normal and malformed human hearts. Circulation 2003, 107: 2467-2474.
66. Lange M, Kaynak B, Forster UB, Tonjes M, Fischer JJ, Grimm C and Schlesinger J, et al. Regulation of muscle development by DPF3, a novel histone acetylation and methylation reader of the BAF chromatin remodeling complex. Genes Dev 2008, 22: 2370-2384.
67. Shirai M, Osugi T, Koga H, Kaji Y, Takimoto E, Komuro I and Hara J, et al. The Polycomb-group gene Rae28 sustains Nkx2.5/Csx expression and is essential for cardiac morphogenesis. J Clin Invest 2002, 110: 177-184.
68. Barth JL, Clark CD, Fresco VM, Knoll EP, Lee B, Argraves WS and Lee KH. Jarid2 is among a set of genes differentially regulated by Nkx2.5 during outflow tract morphogenesis. Dev Dyn 2010, 239: 2024-2033.
69. Toyoda M, Shirato H, Nakajima K, Kojima M, Takahashi M, Kubota M and Suzuki-Migishima R, et al. Jumonji downregulates cardiac cell proliferation by repressing cyclin D1 expression. Dev Cell 2003, 5: 85-97.
70. Kim TG, Chen J, Sadoshima J and Lee Y. Jumonji represses atrial natriuretic factor gene expression by inhibiting transcriptional activities of cardiac transcription factors. Mol Cell Biol 2004, 24: 10151-10160.
71. Schott JJ, Benson DW, Basson CT, Pease W, Silberbach GM, Moak JP and Maron BJ, et al. Congenital heart disease caused by mutations in the transcription factor NKX2-5. Science 1998, 281: 108-111.
72. Tanaka M, Wechsler SB, Lee IW, Yamasaki N, Lawitts JA and Izumo S. Complex modular cis-acting elements regulate expression of the cardiac specifying homeobox gene Csx/Nkx2.5. Development 1999, 126: 1439-1450.
73. Kasahara H, Lee B, Schott JJ, Benson DW, Seidman JG, Seidman CE and Izumo S. Loss of function and inhibitory effects of human CSX/ NKX2.5 homeoprotein mutations associated with congenital heart disease. J Clin Invest 2000, 106: 299-308.
74. Zhu W, Shiojima I, Hiroi Y, Zou Y, Akazawa H, Mizukami M and Toko H, et al. Functional analyses of three Csx/Nkx-2.5 mutations that cause human congenital heart disease. J Biol Chem 2000, 275: 35291-35296.
75. Bruneau BG, Bao ZZ, Tanaka M, Schott JJ, Izumo S, Cepko CL and Seidman JG, et al. Cardiac expression of the ventricle-specific homeobox gene Irx4 is modulated by Nkx2-5 and dHand. Dev Biol 2000, 217: 266-277.
76. Pashmforoush M, Lu JT, Chen H, Amand TS, Kondo R, Pradervand S and Evans SM, et al. Nkx2-5 pathways and congenital heart disease; lossn of ventricular myocyte lineage specification leads to progressive cardiomyopathy and complete heart block. Cell 2004, 117: 373-386.
77. Prall OW, Menon MK, Solloway MJ, Watanabe Y, Zaffran S, Bajolle F and Biben C, et al. An Nkx2-5/Bmp2/Smad1 negative feedback loop controls heart progenitor specification and proliferation. Cell 2007, 128: 947-959.
78. Nimura K, Ura K, Shiratori H, Ikawa M, Okabe M, Schwartz RJ and Kaneda Y. A histone H3 lysine 36 trimethyltransferase links Nkx2-5 to Wolf-Hirschhorn syndrome. Nature 2009, 460: 287-291.
79. Aramaki M, Udaka T, Kosaki R, Makita Y, Okamoto N, Yoshihashi H and Oki H, et al. Phenotypic spectrum of CHARGE syndrome with CHD7 mutations. J Pediatr 2006, 148: 410-414.
80. Schnetz MP, Bartels CF, Shastri K, Balasubramanian D, Zentner GE, Balaji R and Zhang X, et al. Genomic distribution of CHD7 on chromatin tracks H3K4 methylation patterns. Genome Res 2009, 19: 590-601.
81. Zhang X, Guo C, Chen Y, Shulha HP, Schnetz MP, LaFramboise T and Bartels CF, et al. Epitope tagging of endogenous proteins for genomewide ChIP-chip studies. Nat Methods 2008, 5: 163-165.
82. Wang Z, Zang C, Cui K, Schones DE, Barski A, Peng W and Zhao K. Genome-wide mapping of HATs and HDACs reveals distinct functions in active and inactive genes. Cell 2009, 138: 1019-1031.
83. Lindsay EA, Vitelli F, Su H, Morishima M, Huynh T, Pramparo T and Jurecic V, et al. Tbx1 haploinsufficieny in the DiGeorge syndrome region causes aortic arch defects in mice. Nature 2001, 410: 97-101.
84. Randall V, McCue K, Roberts C, Kyriakopoulou V, Beddow S, Barrett AN and Vitelli F, et al. Great vessel development requires biallelic expression of Chd7 and Tbx1 in pharyngeal ectoderm in mice. J Clin Invest 2009, 119: 3301-3310.
85. Bajpai R, Chen DA, Rada-Iglesias A, Zhang J, Xiong Y, Helms J and Chang CP, et al. CHD7 cooperates with PBAF to control multipotent neural crest formation. Nature 2010, 463: 958-962.
86. Li QY, Newbury-Ecob RA, Terrett JA, Wilson DI, Curtis AR, Yi CH and Gebuhr T, et al. Holt-Oram syndrome is caused by mutations in TBX5, a member of the Brachyury (T) gene family. Nat Genet 1997, 15: 21-29.
87. Basson CT, Bachinsky DR, Lin RC, Levi T, Elkins JA, Soults J and Grayzel D, et al. Mutations in human TBX5 [corrected] cause limb and cardiac malformation in Holt-Oram syndrome. Nat Genet 1997, 15: 30-35.
88. Moskowitz IP, Pizard A, Patel VV, Bruneau BG, Kim JB, Kupershmidt S and Roden D, et al. The T-box transcription factor Tbx5 is required for the patterning and maturation of the murine cardiac conduction system. Development 2004, 131: 4107-4116.
89. Bruneau BG, Logan M, Davis N, Levi T, Tabin CJ, Seidman JG and Seidman CE. Chamber-specific cardiac expression of Tbx5 and heart defects in Holt-Oram syndrome. Dev Biol 1999, 211: 100-108.
90. Hatcher CJ, Goldstein MM, Mah CS, Delia CS and Basson CT. Identification and localization of TBX5 transcription factor during human cardiac morphogenesis. Dev Dyn 2000, 219: 90-95.
91. Ghosh TK, Packham EA, Bonser AJ, Robinson TE, Cross SJ and Brook JD. Characterization of the TBX5 binding site and analysis of mutations that cause Holt-Oram syndrome. Hum Mol Genet 2001, 10: 1983-1994.
92. Basson CT, Huang T, Lin RC, Bachinsky DR, Weremowicz S, Vaglio A and Bruzzone R, et al. Different TBX5 interactions in heart and limb defined by Holt-Oram syndrome mutations. Proc Natl Acad Sci USA 1999, 96: 2919-2924.
93. Bruneau BG, Nemer G, Schmitt JP, Charron F, Robitaille L, Caron S and Conner DA, et al. A murine model of Holt-Oram syndrome defines roles of the T-box transcription factor Tbx5 in cardiogenesis and disease. Cell 2001, 106: 709-721.
94. Hiroi Y, Kudoh S, Monzen K, Ikeda Y, Yazaki Y, Nagai R and Komuro I. Tbx5 associates with Nkx2-5 and synergistically promotes cardiomyocyte differentiation. Nat Genet 2001, 28: 276-280.
95. Hatcher CJ, Kim MS, Mah CS, Goldstein MM, Wong B, Mikawa T and Basson CT. TBX5 transcription factor regulates cell proliferation during cardiogenesis. Dev Biol 2001, 230: 177-188.
96. Fan C, Chen Q and Wang QK. Functional role of transcriptional factor TBX5 in pre-mRNA splicing and Holt-Oram syndrome via association with SC35. J Biol Chem 2009, 284: 25653-25663.
97. Murakami M, Nakagawa M, Olson EN and Nakagawa O. A WW domain protein TAZ is a critical coactivator for TBX5, a transcription factor implicated in Holt-Oram syndrome. Proc Natl Acad Sci USA 2005, 102: 18034-18039.
98. Blow MJ, McCulley DJ, Li Z, Zhang T, Akiyama JA, Holt A and Plajzer-Frick I, et al. ChIP-Seq identification of weakly conserved heart enhancers. Nat Genet 2010, 42: 806-810.
99. Carey AH, Kelly D, Halford S, Wadey R, Wilson D, Goodship J and Burn J, et al. Molecular genetic study of the frequency of monosomy 22q11 in DiGeorge syndrome. Am J Hum Genet 1992, 51: 964-970.
100. Lewin MB, Lindsay EA, Jurecic V, Goytia V, Towbin JA and Baldini A. A genetic etiology for interruption of the aortic arch type B. Am J Cardiol 1997, 80: 493-497.
101. Shprintzen RJ. Velo-cardio-facial syndrome: 30 years of study. Dev Disabil Res Rev 2008, 14: 3-10.
102. Jerome LA and Papaioannou VE. DiGeorge syndrome phenotype in mice mutant for the T-box gene, Tbx1. Nat Genet 2001, 27: 286-291.
103. Stoller JZ, Huang L, Tan CC, Huang F, Zhou DD, Yang J and Gelb BD, et al. Ash2l interacts with Tbx1 and is required during early embryogenesis. Exp Biol Med (Maywood) 2010, 235: 569-576.